My watch list
my.chemeurope.com  
Login  

Millipore and MWG-Biotech sign co-marketing agreement to offer integrated solutions to the genomics researcher

Montage Life Science Kits and Automated Biosystems

09-03-2001: Millipore Corporation (NYSE:MIL) and MWG-Biotech (NEMAX:NWU) announced today a non-exclusive agreement in which MWG-Biotech will market Millipore’s new Montage Life Science Kits in conjunction with MWG-Biotech’s Automated Biosystems for several genomics sample preparation applications in Europe, North America, and other selected countries.

The agreement further strengthens the two companies’ competitive edge in the nucleic acid purification field by providing integrated total solutions to the genomics researcher. MWG-Biotech’s Automated Biosystems and Millipore’s Montage sample prep kits are combined into optimal packages that make genomics applications faster, more efficient, highly reproducible and easier to perform in high-throughput conditions.

MWG-Biotech offers its Automated Biosystems series for complete lab automation. This series contains a full range of automated high tech platforms designed for tailor-made solutions to ensure great flexibility, exact process control and high-throughput in a great number of lab processes in molecular biology. Fields of application are the diagnostics of disease-relevant DNA-regions and basic genome research to acquire new data. Millipore’s Montage Life Science kits will be used on MWG-Biotech’s Automated Biosystems platforms to be launched in Q1 of this year for the complete automation of plasmid purification, PCR product purification, sequencing reaction set-up, cycling, and removal of non-incorporated terminators.

Millipore’s Montage Life Science Kits combine Millipore’s innovative size exclusion separation platforms with high quality reagents and robust protocols that make nucleic acid sample preparations fast, easy, and automation-friendly, and provide the customer with high quality DNA template preps.

More about MWG Biotech
  • News

    Eurofins Medigenomix / MWG Biotech sequence Wacker Chemie AG's bacterial protein production strain

    Eurofins Medigenomix GmbH / MWG Biotech AG have finalised a genome sequencing project with Wacker Chemie AG for the analysis of the genetic differences between Wacker's proprietary industrial protein production E. coli strain and its corresponding parental strain. The successful sequencing ... more

    New RoboSeq 2500 DT automated biosystem for molecular biology applications

    With the new fully automated lab robot RoboSeq 2500 DT Disposable Tips, MWG-Biotech announces the official commercialization of the latest member of its successful series of Automated Biosystems. The new system was officially launched on Biotechnica in Hanover at the beginning of Octobe ... more

    MWG-Biotech - Pan® Oligo Sets to make your own DNA chip

    Pan® Oligo Sets is the brand name for MWG-Biotech’s new oligonucleotide sets that enable customers to produce their own oligonucleotide microarrays (DNA chips). The sets are based on the competence and the success of MWG-Biotech’s Pan® Array series of catalogue DNA chips and on the high ... more

  • Companies

    MWG Biotech AG

    MWG Biotech is an international provider of genomics products and services in DNA Oligonucleotide Synthesis, siRNA Synthesis, and DNA Sequencing. With strong customer orientientation, fast, web-based service and high quality products we provide the basis for success in the life sciences for ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE